Chemotherapy
498 articles
Traveling with Pancreatic Cancer
Drs. Sunil Hingorani and David Zhen outline the ways to make traveling with pancreatic cancer easier if you are in treatment.
The Impact of BRCA Is Broader Than Breast and Ovarian Cancer
Rona Greenberg discusses the impact of BRCA2 on her family, and her search for the best clinical trial for her needs after her pancreatic cancer diagnosis.
Alternating Protocols to Attack Pancreatic Cancer
Working with his oncologist, Dr. Mark Fishman decided to follow non-standard alternating protocols to treat his pancreatic cancer.
Planning for My Future
When diagnosed with Stage IV PNET at the age of 30, Amy Zaterman found a doctor who believed in her and didn’t give up. Learn more about her inspiring story.
Finding the Best Diabetes Drug for Pancreatic Cancer Patients
With all the various drugs out there, Dr. James Flory wants to establish which diabetes drug works best for pancreatic cancer patients. Read his expert advice.
A Clinical Trial for a Rare Pancreatic Cancer
Allison Lippman Kuban was trying to tolerate a difficult chemotherapy regimen when a mutation was found that qualified her for a clinical trial.
Kicking Pancreatic Cancer’s Butt
When Margie Goldsmith was diagnosed with an IPMN she made it her goal to beat that pancreatic cancer. It took two more tries but she did it.
Putting the Immune System on the Offensive
A discussion of immunology in cancer treatment, focusing on the work of Elizabeth Jaffe, M.D., and her cancer vaccine and checkpoint inhibitors.
Novel Drug Therapy Kills Pancreatic Cancer Cells by Reducing Levels of Antioxidants
New research finds that reducing antioxidants can help kill pancreatic cancer cells, suggesting a new direction for treatment.
The First Line of Defense against Pancreatic Cancer
Drs. Allyson Ocean and David Tuveson explain why pancreatic cancer patients should participate in clinical trials at the time of diagnosis.
Two Enzymes May Predict Pancreatic Cancer Severity and Development
Dr. Alexandra Newton and her lab have found that the relationship between two enzymes common to cancer may play a role in pancreatic cancer prognosis.
New Study Aims to Reduce Recurrence Risk for Select Patients
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
A Year in Review: 2022 in Research
What progress was made in pancreatic treatment and screening? Learn about the major pancreatic cancer developments of 2022.
What to Eat—and What to Avoid—When You Have Pancreatic Cancer
The disease and treatment for pancreatic cancer affect the digestive system. Dietitian L.J. Amaral guides you to the best nutrition sources.
No Time To Lose
Eduardo Servin acted pretty quickly when he began itching all over and noticed that he was jaundiced. He believes this saved his life.